VelaVigo
PrivateLast Round
VC Round
Jul 28, 2025
Total Funding Raised
$100M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
VelaVigo operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a VC Round in July 2025.
VelaVigo is a biopharmaceutical company that specializes in the discovery and development of multispecific antibodies and antibody-drug conjugates for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VelaVigo Comparables
Compare VelaVigo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 90% | |
| Duality Biotherapeutics Inc | 82% | |
| BioNTech SE | 79% |
For institutional investors. Book with your work email.
VelaVigo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 28, 2025 | ||||
| Pre Seed | Dec 31, 2024 | ||||
| Angel | Nov 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VelaVigo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | VC Round, Pre Seed, Angel |
| Legend Star | VC Round, Pre Seed |
| Shanghai Healthcare Capital | VC Round, Pre Seed |
| Zoo Capital | VC Round, Pre Seed |
| Highlight Capital | VC Round, Pre Seed |
| Northern Light Venture Capital | VC Round |
| Delian Capital | VC Round, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Dec 5, 2025
Monthly visitors grew 1573% MoM, from 113 to 1.9K.
For institutional investors. Book with your work email.
VelaVigo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VelaVigo's valuation, stock price, and market status.
Is VelaVigo a public or private company?
VelaVigo is a private company.
What is the current stock price of VelaVigo?
VelaVigo is a private company, so its shares have no public market price. Caplight tracks VelaVigo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VelaVigo worth (valuation)?
Valuation information for VelaVigo is not publicly available.
Can I buy VelaVigo stock?
VelaVigo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VelaVigo's last funding round?
VelaVigo's most recent funding round was VC Round on July 28, 2025.
Who are the main investors in VelaVigo?
Key investors in VelaVigo include HighLight Capital, Shanghai Healthcare Capital, Shunwei Capital, Panacea Venture Healthcare.
Will VelaVigo IPO soon?
No public IPO plans have been announced for VelaVigo.
How can I track VelaVigo secondary market activity?
Caplight tracks bids, offers, and trades in VelaVigo's shares on secondary markets.